Picture

BioNeex @BioNeex_

The first Biopharma R&D open Exchange Platform for Licensing and Co-Development Partnerships of Drug Candidates bioneex.com Syracuse, New York, US Joined June 2018
  • Tweets
    404
  • Followers
    121
  • Following
    367
  • Likes
    168
BioNeex_ Profile Picture

BioNeex @BioNeex_

a week ago

story.cd/AAZUI0

BioNeex_ Profile Picture

BioNeex @BioNeex_

2 years ago

story.cd/AAXCi8

BioNeex_ Profile Picture

BioNeex @BioNeex_

2 years ago

A peptide-peptide nucleic acid composed of a cell-penetrating peptide conjugated to a gene target-specific antisense peptide nucleic acid sequence for improved delivery into the bacterial cytoplasm. app.bioneex.com/drug-candidate…

BioNeex_ Profile Picture

BioNeex @BioNeex_

2 years ago

A therapeutic candidate developed through a novel DNA-based drug delivery and development platform. Simplified method to deliver and use the patient’s own cells to manufacture the required proteins, T-cells, and antibodies in vivo for cancers. app.bioneex.com/drug-candidate…

BioNeex_ Profile Picture

BioNeex @BioNeex_

2 years ago

A cell-penetrating peptide conjugated to a gene target-specific antisense peptide nucleic acid sequence for improved delivery into the bacterial cytoplasm. app.bioneex.com/drug-candidate… #biotech, #Pharmaceuticals, #investors, #oncology, #Neurology, #hematology, #Immunology

BioNeex_ Profile Picture

BioNeex @BioNeex_

2 years ago

A dual acting NLRP3 protein inhibitor that through its mechanism of action can reduce/preclude neurotoxicity in the CNS and PNS, specifically created by chemotherapy. app.bioneex.com/drug-candidate… #biotech, #investors, #oncology, #Neurology, #hematology, #Immunology

BioNeex_ Profile Picture

BioNeex @BioNeex_

2 years ago

A TRPV1 receptor modulator with a proprietary formulation that contains purified synthetic cannabidiol with improved bioavailability and blood brain barrier transmission. app.bioneex.com/drug-candidate… #biotech, #investors, #oncology, #Neurology, #hematology, #Immunology

BioNeex_ Profile Picture

BioNeex @BioNeex_

2 years ago

A drug candidate with no adverse effects, based on a platform, which not only reduces but also prevents high levels of LDL cholesterol. app.bioneex.com/drug-candidate… #biotech, #Pharmaceuticals, #Science,#partnerships, #investors, #oncology, #Neurology, #hematology, #Immunology

BioNeex_ Profile Picture

BioNeex @BioNeex_

2 years ago

A gene therapy to treat vision loss caused by RPGRIP1 mutations uses the novel Anc80 vector technology that has a superior delivery profile compared to commonly used AAVs. app.bioneex.com/drug-candidate… #biotech, #investors, #oncology, #Neurology, #hematology, #Immunology

BioNeex_ Profile Picture

BioNeex @BioNeex_

2 years ago

A first-in-class allogeneic innate cell therapy with promising human data showing 80% tumour necrosis in end-stage carcinoma patients at low dose. app.bioneex.com/drug-candidate… #biotech, #Pharmaceuticals, #partnerships, #investors, #oncology, #Neurology, #hematology, #Immunology

BioNeex_ Profile Picture

BioNeex @BioNeex_

2 years ago

A first-in-class antibiotic in the preclinical stage for drug-resistant Gram-negative pathogens, including N. gonorrhoeae and Pseudomonas aeruginosa. app.bioneex.com/drug-candidate… #biotech, #Pharmaceuticals, #partnerships, #investors, #oncology, #Neurology, #hematology, #Immunology

BioNeex_ Profile Picture

BioNeex @BioNeex_

2 years ago

A non-antibiotic drug candidate for bacterial infections, which blocks the formation of disease-causing toxins without killing the pathogen and inhibits biofilm formation. app.bioneex.com/drug-candidate… #biotech, #investors, #oncology, #Neurology, #hematology, #Immunology

BioNeex_ Profile Picture

BioNeex @BioNeex_

2 years ago

Cancer vaccine based on proprietary preparation of a protozoan, considered non-pathogenic to humans that overcomes the local cancer defenses of the Tumor Microenvironment. app.bioneex.com/drug-candidate… #biotech, #investors, #oncology, #Neurology, #hematology, #Immunology

BioNeex_ Profile Picture

BioNeex @BioNeex_

2 years ago

A novel cancer vaccine based on proprietary preparation of modified protozoan that replicates in tumor cells and secretes anti-cancer cytokine, human Interleukin-15. app.bioneex.com/drug-candidate… #biotech, #Pharmaceuticals, #Science, #oncology, #Neurology, #hematology, #Immunology

BioNeex_ Profile Picture

BioNeex @BioNeex_

2 years ago

A modified non-pathogenic protozoan that restores immune competence in the tumor microenvironment and provokes potent anti-cancer immune response. app.bioneex.com/drug-candidate… #biotech, #Pharmaceuticals,#partnerships, #investors, #oncology, #Neurology, #hematology, #Immunology

BioNeex_ Profile Picture

BioNeex @BioNeex_

2 years ago

A glycooptimized recombinant follicle-stimulating hormone produced by proprietary platform. It combines safety of recombinant production and human glycosylation. app.bioneex.com/drug-candidate… #biotech, #Science,#partnerships, #investors,#oncology, #Neurology, #hematology, #Immunology

BioNeex_ Profile Picture

BioNeex @BioNeex_

2 years ago

A drug candidate, consisting of a human cell expression system, which offers advantages over recombinant FVIIa forms like missing immunogenic glycan structures. app.bioneex.com/drug-candidate… #biotech, #partnerships, #investors, #oncology, #Neurology, #hematology, #Immunology

BioNeex_ Profile Picture

BioNeex @BioNeex_

2 years ago

A novel drug candidate, designed to retain all Fv-mediated anti-tumor activities, largely improve anti-tumor efficacy via ADCC and reduce side effects. app.bioneex.com/drug-candidate… #biotech, #Pharmaceuticals, #partnerships, #investors, #oncology, #Neurology, #hematology, #Immunology

BioNeex_ Profile Picture

BioNeex @BioNeex_

2 years ago

A novel drug candidate, designed to retain all Fv-mediated anti-tumor activities, largely improve anti-tumor efficacy via ADCC and reduce side effects. app.bioneex.com/drug-candidate… #biotech, #Pharmaceuticals, #partnerships, #investors, #oncology, #Neurology, #hematology, #Immunology

BioNeex_ Profile Picture

BioNeex @BioNeex_

2 years ago

A glycooptimized anti-PD-L1 monoclonal antibody that combines strong inhibition of the PD1/PD-L1 interaction with improved T cell re-activation. app.bioneex.com/drug-candidate… #biotech, #Pharmaceuticals, #Science,#partnerships, #investors, #oncology,#Neurology, #hematology,#Immunology

Trends for United States

Good Sunday
51,9 B posts
NFL Sunday
13,5 B posts
#HardRockBet
#HereWeGo
2.629 posts
POUNDING
11,7 B posts
#sundayvibes
4.254 posts
Rand Paul
25 B posts
Who Dey
8.492 posts
Football Sunday
4.940 posts
Go Bills
12,5 B posts
FastSet
3.879 posts
#MchoiceMintAwards2025
2,01 Mn posts
Creators
48,5 B posts
#PhinsUp
2.945 posts
Go Browns
1.245 posts
Samaria
3.807 posts
Charlotte
192 B posts
Blessed Sunday
26 B posts
Jania
3.616 posts
Jamo
3.135 posts

You might like

Accelerating Innovation Through Genetically Engineered Mouse Models (GEMMS) and Preclinical Services
GemPharmatech
@GPharmatech
248 Followers
The drug development accelerator-create more drugs with better profile in clinical trials- we valorize your pipeline! #cardiomyocytes #stemcells #iPS #biotech
myriamed
@myriamed_de
2K Followers
Boutique healthcare consulting firm help businesses achieve their growth expectations through bespoke interventions in marketing and sales force excellence
WhiteSpace
@white_space_15
218 Followers
Founder & CTO @ @labguru. Tweeting about Science, Lab Informatics and more. Views are my own. https://t.co/Z6eXa4Wvgb…
Jonathan Gross
@rubp
3K Followers
Heal The Planet Holds Special Consultative Status with U.N. We're as a result of Global minds & Organizations with A Redefined Global Agenda to Heal Our World.
Heal The Planet
@healdeplanet
815 Followers
Precision Electronic Glass Inc. has been supplying custom glass components to OEM's since 1962.
Precision Electronic ...
@peg_glass
148 Followers